Barclays lowered the firm’s price target on MetLife (MET) to $95 from $96 and keeps an Overweight rating on the shares following the Q4 report.

In a report released today, Alex Scott from Barclays maintained a Buy rating on Metlife (MET – Research Report), with a price target of $95.00.

MetLife Inc. closed 6.04% below its 52-week high of $89.05, which the company achieved on November 27th.

Learn more about whether Erie Indemnity Company or MetLife, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

MetLife (MET) delivered earnings and revenue surprises of -2.35% and 2.65%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

(Reuters) - MetLife (NYSE: MET) on Wednesday reported a rise in its fourth-quarter profit as it earned more in premiums and ...

(MET) on Wednesday reported fourth-quarter net income of $1.24 billion. On a per-share basis, the New York-based company said it had profit of $1.78.

The insurance industry is anticipated to have gained on rate hikes, strong retention rates, new business growth, an active ...

MetLife (NYSE:MET – Get Free Report) will likely be posting its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect MetLife to post earnings of $2.13 per ...

Learn more about whether MetLife, Inc. or Principal Financial Group, Inc. is a better investment based on AAII's A+ Investor ...